tirzepatide, assuming they would all equally influence the risk of macular degeneration, whereas that may not be the case
Wegovy is the only option of these three that has specifically been approved for use as a weight loss medication, only really differing from Ozempic by its recommended dosages
In one clinical trial on Wegovy, the average weight loss was 15% in 68 weeks
Intestinal fibrosis is a clinical feature of UC but rarely causes strictures 205,206
We offer insurance-covered programs and accept most insurances, including Medicare
In the SURPASS-2 trial (published in The New England Journal of Medicine in 2021), tirzepatide at 5, 10, and 15 mg was compared with semaglutide 1 mg in 1,879 adults with type 2 diabetes on metformin over 40 weeks